Phase II Evaluation of Temozolomide and 13-cis-Retinoic Acid for the Treatment of Recurrent and Progressive Malignant Glioma: A North American Brain Tumor Consortium Study Purpose: We examined the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback